Skip to main content

Tierney David S's Form 4 filing

Catalyst Pharmaceuticals, Inc. (CPRX) · filed May 24, 2022

Accession no.
0001161697-22-000261
Filed
May 24, 2022
Trade date
May 20, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 1 derivative transaction. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Tierney David SCIK 0001292636Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 20, 2022Common stock, par value $0.001 per shareMOption exerciseAcquired+20,000$2.53+$50,600328,207Direct
May 20, 2022Common stock, par value $0.001 per shareSSaleDisposed−20,000–F2–308,207Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 20, 2022Common StockMOption exerciseDisposed−20,000$0.00$0252,333Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

12,803 shares were sold at a price of $7.03 per share, 5,626 were sold at a price of $7.04 per share, and 1,571 were sold at a price of $7.05 per share.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)